The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 3,901–4,000 of 31,469
González‐González, J. G., Violante-Cumpa, J. R., Zambrano-Lucio, M., Burciaga-Jimenez, E., Morales, P., García-Campa, M., Solís, R. C., González-Colmenero, A. D., & Rodríguez‐Gutiérrez, R. (2022) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-022-00542-5 · Cited by 98
Ueta, K., Ishihara, T., Matsumoto, Y., Oku, A., Nawano, M., Fujita, T., Saito, A., & Arakawa, K. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.09.038 · Cited by 84
Kaser, S., Moschen, A. R., Kaser, A., Ludwiczek, O., Ebenbichler, C. F., Vogel, W., Jaschke, W. R., Patsch, J. R., & Tilg, H. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01543.x · Cited by 86
Aguirre, V., Stylopoulos, N., Grinbaum, R., & Kaplan, L. M. (2008) · Obesity · doi:10.1038/oby.2008.502 · Cited by 85
Morı́nigo, R., Vidal, J., Lacy, A. M., Delgado, S., Casamitjana, R., & Gomis, R. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31815f6e77 · Cited by 86
Tsochatzis, E. A., Papatheodoridis, G., Hadziyannis, E. S., Georgiou, A. N., Kafiri, G., TINIAKOS, D. G., Manesis, E. K., & Archimandritis, A. J. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802085387 · Cited by 84
Azuma, K., Kadowaki, T., Cetinel, C., Kadota, A., El‐Saed, A., Kadowaki, S., Edmundowicz, D., Nishio, Y., Sutton‐Tyrrell, K., Okamura, T., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.03.021 · Cited by 86
Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients
Gharibeh, M. Y., Tawallbeh, G. M. A., Abboud, M. M., Radaideh, A. M., Alhader, A. A., & Khabour, O. F. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.05.003 · Cited by 85
Jiménez‐Pavón, D., Konstabel, K., Bergman, P., Ahrens, W., Pohlabeln, H., Hadjigeorgiou, C., Siani, A., Iacoviello, L., Molnár, D., Henauw, S. D., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-172 · Cited by 85
Relationship between hepatitis C and microalbuminuria: Results from the NHANES III
Liangpunsakul, S., & Chalasani, N. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.00080.x · Cited by 85
Dall’Asta, C., Paganelli, M., Morabito, A., Vedani, P., Barbieri, M., Paolisso, G., Folli, F. B., & Pontiroli, A. E. (2009) · Obesity · doi:10.1038/oby.2009.320 · Cited by 87
Swarbrick, M. M., Austrheim-Smith, I. T., Stanhope, K. L., Loan, M. D. V., Ali, M. R., Wolfe, B. M., & Havel, P. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0452-8 · Cited by 84
Mikus, C. R., Oberlin, D. J., Libla, J. L., Boyle, L. J., & Thyfault, J. P. (2012) · Diabetologia · doi:10.1007/s00125-012-2490-8 · Cited by 88
Reinehr, T., Roth, C. L., Alexy, U., Kersting, M., Kiess, W., & Andler, W. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802913 · Cited by 85
Lupin kernel fibre-enriched foods beneficially modify serum lipids in men
Hall, R. S., Johnson, S. K., Baxter, A. L., & Ball, M. J. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602077 · Cited by 87
Kadowaki, T., & Kondo, K. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12092 · Cited by 86
Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes
Krzyżanowska, K., Zemany, L., Krugluger, W., Schernthaner, G.-H., Mittermayer, F., Schnack, C., Rahman, R. A., Brix, J. M., Kahn, B. B., & Schernthaner, G. (2008) · Diabetologia · doi:10.1007/s00125-008-1009-9 · Cited by 86
Is Inflammatory Bowel Disease a Risk Factor for Early Atherosclerosis?
Dağlı, N., Poyrazoğlu, O. K., Dağlı, A. F., Şahbaz, F., Karaca, I., Kobat, M. A., & Bahçecioğlu, İ. H. (2009) · Angiology · doi:10.1177/0003319709333869 · Cited by 84
Stanley, T. L., Feldpausch, M. N., Oh, J.-H., Branch, K. L., Lee, H., Torriani, M., & Grinspoon, S. K. (2014) · JAMA · doi:10.1001/jama.2014.8334 · Cited by 85
ADIPOQ Polymorphisms, Monounsaturated Fatty Acids, and Obesity Risk: The GOLDN Study
Warodomwichit, D., Shen, J., Arnett, D. K., Tsai, M. Y., Kabagambe, E. K., Peacock, J. M., Hixson, J. E., Straka, R. J., Province, M. A., An, P., et al. (2009) · Obesity · doi:10.1038/oby.2008.583 · Cited by 85
Enhanced insulin sensitivity using electroacupuncture on bilateral Zusanli acupoints (ST 36) in rats
Chang, S., Lin, K.-J., Lin, R.-T., et al. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.05.005 · Cited by 85
Atabek, M. E., & Pirgon, Ö. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.2.187 · Cited by 85
Brinkworth, G. D., Noakes, M., Buckley, J. D., & Clifton, P. M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.07.019 · Cited by 84
Royal Jelly Ameliorates Insulin Resistance in Fructose-Drinking Rats
Zamami, Y., Takatori, S., Goda, M., et al. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.2103 · Cited by 85
Batis, C., Méndez, M. A., Gordon‐Larsen, P., Sotres‐Alvarez, D., Adair, L. S., & Popkin, B. M. (2015) · Public Health Nutrition · doi:10.1017/s1368980014003103 · Cited by 85
Murphy, M. K., Hall, J. E., Adams, J. M., Lee, H., & Welt, C. K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1085 · Cited by 85
Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity
Johansson, L. E., Lindblad, U., Larsson, C., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0426 · Cited by 85
Zhu, L., Baker, S. S., Liu, W., Tao, M., Patel, R. A., Nowak, N. J., & Baker, R. D. (2010) · Metabolism · doi:10.1016/j.metabol.2010.10.003 · Cited by 88
Association of Insulin Resistance and Inflammation With Peripheral Arterial Disease
Pande, R. L., Perlstein, T. S., Beckman, J. A., & Creager, M. A. (2008) · Circulation · doi:10.1161/circulationaha.107.721878 · Cited by 84
Chen, M. (2006) · Human Reproduction · doi:10.1093/humrep/del175 · Cited by 86
Valenti, L. V. C., Moscatiello, S., Vanni, E., Fracanzani, A. L., Bugianesi, E., Fargion, S. R., & Marchesini, G. (2010) · QJM · doi:10.1093/qjmed/hcq170 · Cited by 82
Kuhl, J., Hilding, A., �stenson, C. G., Grill, V., Efendić, S., & B�venholm, P. (2004) · Diabetologia · doi:10.1007/s00125-004-1614-1 · Cited by 85
Hostility predicts metabolic syndrome risk factors in children and adolescents.
Räikkönen, K., Matthews, K. A., & Salomon, K. (2003) · Health Psychology · doi:10.1037/0278-6133.22.3.279 · Cited by 88
Nilsson, P. M., Engström, G., Hedblad, B., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000249638.01416.4b · Cited by 85
Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome
Schmidt, T. H., Khanijow, K., Cedars, M. I., Huddleston, H. G., Pasch, L. A., Wang, E. T., Lee, J., Zane, L. T., & Shinkai, K. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.4498 · Cited by 87
Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis
Kessoku, T., Imajo, K., Honda, Y., Kato, T., Ogawa, Y., Tomeno, W., Kato, S., Mawatari, H., Fujita, K., Yoneda, M., et al. (2016) · Scientific Reports · doi:10.1038/srep22251 · Cited by 85
Muralimanoharan, S., Gao, X., Weintraub, S. T., Myatt, L., & Maloyan, A. (2016) · Autophagy · doi:10.1080/15548627.2016.1156822 · Cited by 83
Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile
Cotrim, H. P., Parise, E. R., de Oliveira, C. P. M. S., Leite, N., Martinelli, A. D. L. C., Galizzi, J., Silva, R. D. C., de Mattos, Â. A., Pereira, L. M. M. B., de Amorim, W. P. D., et al. (2011) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31584-4 · Cited by 85
Laws, S. M., Gaskin, S., Woodfield, A., Srikanth, V. K., Bruce, D. G., Fraser, P. E., Porter, T., Newsholme, P., Wijesekara, N., Burnham, S. C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09577-4 · Cited by 98
Florez, J. C., Sjögren, M., Burtt, N. P., Orho‐Melander, M., Schayer, S., Sun, M. W., Almgren, P., Lindblad, U., Tuomi, T., Gaudet, D., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3313 · Cited by 84
Jensterle, M., Pirš, B., Goričar, K., Dolžan, V., & Janež, A. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1868-1 · Cited by 86
Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M., Shulman, G. I., McVeety, J. C., & Horwitz, R. I. (2003) · Stroke · doi:10.1161/01.str.0000071108.00234.0e · Cited by 84
Lanfranco, F., Zirilli, L., Baldi, M., Pignatti, E., Corneli, G., Ghigo, E., Aimaretti, G., Carani, C., & Rochira, V. (2008) · Bone · doi:10.1016/j.bone.2008.05.011 · Cited by 105
Gibbs, B. B., Gabriel, K. P., Reis, J. P., Jakicic, J. M., Carnethon, M. R., & Sternfeld, B. (2015) · Diabetes Care · doi:10.2337/dc15-0226 · Cited by 85
Fraser, A., Williams, D. M., & Lawlor, D. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013882 · Cited by 84
Andreozzi, F., Procopio, M. C., Greco, A., Mannino, G. C., Miele, C., Raciti, G. A., Iadicicco, C., Bèguinot, F., Pontiroli, A. E., Hribal, M. L., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2116-6 · Cited by 92
Association of obesity with leukocyte count in obese individuals without metabolic syndrome
Ryder, E., Diez‐Ewald, M., Mosquera, J., Fernández, É., Pedreáñez, A. B., Vargas, R., Peña, C., & Fernández, N. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.09.002 · Cited by 84
Shida, T., Akiyama, K., Oh, S., Sawai, A., Isobe, T., Okamoto, Y., Ishige, K., Mizokami, Y., Yamagata, K., Onizawa, K., et al. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1377-3 · Cited by 87
Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation
Ekblad, L. L., Johansson, J. J., Helin, S., Viitanen, M. H., Laine, H. K., Puukka, P. J., Jula, A., & Rinne, J. O. (2018) · Neurology · doi:10.1212/wnl.0000000000005214 · Cited by 89
Mohan, V., Gayathri, R., Jaacks, L. M., Lakshmipriya, N., Anjana, R. M., Spiegelman, D. L., Jeevan, R. G., Balasubramaniam, K. K. G., Shobana, S., Jayanthan, M., et al. (2018) · Journal of Nutrition · doi:10.1093/jn/nxx001 · Cited by 86
Green, C., Pramfalk, C., Charlton, C. A., Gunn, P. J., Cornfield, T., Pavlides, M., Karpe, F., & Hodson, L. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000871 · Cited by 85
Zeng, Z. Y., Liu, S. X., Xu, H. F., Xu, X., Liu, X., & Zhao, X. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13878 · Cited by 84
Dikaiakou, E., Vlachopapadopoulou, E. A., Paschou, S. Α., Athanasouli, F., Panagiotopoulos, Ι., Kafetzi, M. L., Fotinou, A., & Michalacos, S. (2020) · Endocrine · doi:10.1007/s12020-020-02374-6 · Cited by 84
Moreira, N. C. D. V., Hussain, A., Bhowmik, B., Mdala, I., Siddiquee, T., Fernandes, V. O., Montenegro, R. M., & Meyer, H. E. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.05.043 · Cited by 84
Thymic stromal lymphopoietin induces adipose loss through sebum hypersecretion
Choa, R., Tohyama, J., Wada, S., Meng, H., Hu, J., Okumura, M., May, R. M., Robertson, T. F., Pai, R.-A. L., Nace, A., et al. (2021) · Science · doi:10.1126/science.abd2893 · Cited by 88
Yamaoka‐Tojo, M., Tojo, T., Takahira, N., Matsunaga, A., Aoyama, N., Masuda, T., & Izumi, T. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-17 · Cited by 86
Ceperuelo‐Mallafré, V., Näf, S., Escoté, X., Caubet, E., Gómez, J. M., Miranda, M., Chacón, M. R., González‐Clemente, J. M., Gallart, L., Gutiérrez, C., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0764 · Cited by 84
Lee, Y., Lim, S. K., Hong, E. S., Kim, J. H., Moon, M. K., Chun, E. J., Choi, S. I., Kim, Y., Park, Y. J., Park, K. S., et al. (2012) · Clinical Endocrinology · doi:10.1111/cen.12134 · Cited by 84
Higashi, Y., Sasaki, S., Nakagawa, K., Kimura, M., Noma, K., Sasaki, S., Hara, K., Matsuura, H., Goto, C., Oshima, T., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00630-2 · Cited by 84
C‐reactive protein and metabolic syndrome in women with previous gestational diabetes
Cianni, G. D., Lencioni, C., Volpe, L., Ghio, A., Cuccuru, I., Pellegrini, G., Benzi, L., Miccoli, R., & Prato, S. D. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.661 · Cited by 83
Serum 25(OH)D and Type 2 Diabetes Association in a General Population
Husemoen, L. L. N., Thuesen, B. H., Fenger, M., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1309 · Cited by 84
Aron‐Wisnewsky, J., Julia, Z., Poitou, C., Bouillot, J., Basdevant, A., Chapman, M. J., Clément, K., & Guérin, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2378 · Cited by 87
Behrens, G. M. N., Boerner, A. R., Weber, K. K., van den Hoff, J., Ockenga, J., Brabant, G. E., & Schmidt, R. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15626 · Cited by 83
Role of Adipokines in the Obesity???Inflammation Relationship: The Effect of Fat Removal
Esposito, K., Giugliano, G., Scuderi, N., & Giugliano, D. (2006) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000232281.49432.ce · Cited by 88
Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes
Zhou, H., Li, Y., Wang, M., et al. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.54 · Cited by 84
Herter‐Aeberli, I., Jung, A., Murer, S. B., Wildhaber, J. H., Brooks-Wildhaber, J., Knöpfli, B. H., & Zimmermann, M. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1169 · Cited by 82
Identification of a dietary pattern associated with greater cardiometabolic risk in adolescence
Appannah, G., Pot, G. K., Huang, R., Oddy, W. H., Beilin, L. J., Mori, T. A., Jebb, S. A., & Ambrosini, G. L. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.04.007 · Cited by 83
Serum resistin and adiponectin levels in women with polycystic ovary syndrome
Yılmaz, M., Bukan, N. C., Demirci, H., Ozturk, C. S., Kan, E., Ayvaz, G., & Arslan, M. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802653833 · Cited by 84
Mueller, A., Schöfl, C., Dittrich, R., Cupisti, S., Oppelt, P. G., Schild, R., Beckmann, M. W., & Häberle, L. (2009) · Human Reproduction · doi:10.1093/humrep/dep285 · Cited by 86
Arias, N., Macarulla, M. T., Aguirre, L., Martínez-Castaño, M. G., & Portillo, M. P. (2013) · Genes & Nutrition · doi:10.1007/s12263-013-0361-7 · Cited by 91
Depression and Type 2 Diabetes Mellitus: The Multiethnic Study of Atherosclerosis
Golden, S. H., Lee, H. B., Schreiner, P. J., Roux, A. V. D., Fitzpatrick, A. L., Szklo, M., & Lyketsos, C. G. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3180f61c5c · Cited by 84
Legry, V., Cottel, D., Ferrières, J., Arveiler, D., Andrieux, N., Bingham, A., Wagner, A., Ruidavets, J., Ducimetière, P., Amouyel, P., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.019 · Cited by 84
Schaalan, M. F., El-Abhar, H. S., Barakat, M., & El-Denshary, E. S. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.02.003 · Cited by 86
Wirström, T., Hilding, A., Gu, H. F., Östenson, C., & Björklund, A. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.045583 · Cited by 85
Luef, G. J., Abraham, I., Trinka, E., Alge, A., Windisch, J., Daxenbichler, G., Unterberger, I., Seppi, K., Lechleitner, M., Krämer, G., et al. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(01)00317-5 · Cited by 84
Postprandial hyperlipidemia: another correlate of the “hypertriglyceridemic waist” phenotype in men
Blackburn, P. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.06.001 · Cited by 84
Kalaitzakis, E., Bosaeus, I. G., Öhman, L., & Bjornsson, E. S. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.808 · Cited by 84
Öztürk, K., Uygun, A., Guler, A. K., Demirci, H., Ozdemir, C., Cakir, M., Sakın, Y. S., Türker, T., Sarı, S., Demirbaş, Ş., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.009 · Cited by 84
Sierra‐Johnson, J., Somers, V. K., Kuniyoshi, F. H. S., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.06.029 · Cited by 84
Raben, A., Møller, B., Flint, A., Vasilaras, T. H., Møller, A. C., Holst, J. J., & Astrup, A. V. (2011) · Food & Nutrition Research · doi:10.3402/fnr.v55i0.5961 · Cited by 93
Harzallah, A., Hammami, M., Kępczyńska, M. A., Hislop, D. C., Arch, J. R. S., Cawthorne, M. A., & Zaibi, M. S. (2016) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2016.1148053 · Cited by 85
Lin, Y., Chang, P., Lin, H.-F., Liu, K. G., Chang, M., & Ni, Y. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.029 · Cited by 86
Peplies, J., Börnhorst, C., Günther, K., Fraterman, A., Russo, P., Veidebaum, T., Tornaritis, M. J., Henauw, S. D., Mårild, S., Molnár, D., et al. (2016) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-016-0424-4 · Cited by 83
Taniguchi, A., Fukushima, M., Sakai, M., Kataoka, K., Nagata, I., Doi, K., Arakawa, H., Nagasaka, S., Tokuyama, K., & Nakai, Y. (2000) · Metabolism · doi:10.1053/meta.2000.7735 · Cited by 82
Ala92 Type 2 Deiodinase Allele Increases Risk for the Development of Hypertension
Gumieniak, O., Perlstein, T. S., Williams, J. S., Hopkins, P. N., Brown, N. J., Raby, B. A., & Williams, G. H. (2007) · Hypertension · doi:10.1161/01.hyp.0000256295.72185.fd · Cited by 84
Guilder, G. P. V., Hoetzer, G. L., Smith, D. T., Irmiger, H. M., Greiner, J. J., Stauffer, B. L., & DeSouza, C. A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00072.2005 · Cited by 84
Cardiopulmonary Impairment in Young Women with Polycystic Ovary Syndrome
Orio, F., Giallauria, F., Palomba, S., Cascella, T., Manguso, F., Vuolo, L., Russo, T., Tolino, A., Lombardi, G., Colao, A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0216 · Cited by 84
Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients
Brooks-Worrell, B. M., Reichow, J. L., Goel, A., Ismail, H., & Palmer, J. P. (2011) · Diabetes Care · doi:10.2337/dc10-0579 · Cited by 83
da Silva, C. D. C., Zambon, M. P., Vasques, A. C. J., Rodrigues, A. M. D. B., Camilo, D. F., Antonio, M. Â. R. D. G. M., Cassani, R. S. L., & Geloneze, B. (2014) · Revista Paulista de Pediatria · doi:10.1590/0103-0582201432210713 · Cited by 86
Palomba, S., Falbo, A. I., Chiossi, G., Orio, F., Tolino, A., Colao, A., Sala, G. B. L., & Zullo, F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1214 · Cited by 83
Hofsø, D., Jenssen, T. G., Bollerslev, J., Ueland, T., Godang, K., Stümvoll, M., Sandbu, R., Røislien, J., & Hjelmesaeth, J. S. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0804 · Cited by 83
Risk Factors Associated With Non-Alcoholic Fatty Liver Disease in Indians: A Case–Control Study
Singh, S. P., Singh, A., Misra, D., Misra, B., Pati, G. K., Panigrahi, M. K., Kar, S. K., Bhuyan, P., Pattnaik, K., Meher, C., et al. (2015) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2015.09.001 · Cited by 83
Park, E., Edirisinghe, I., Wei, H., Vijayakumar, L. P., Banaszewski, K., Cappozzo, J. C., & Burton‐Freeman, B. M. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500845 · Cited by 83
Seabra, A., Katzmarzyk, P. T., Carvalho, M. J., Seabra, A., Coelho-e-Silva, M. J., Abreu, S., Vale, S., Póvoas, S. C. A., Nascimento, H., Belo, L., et al. (2016) · Journal of Sports Sciences · doi:10.1080/02640414.2016.1140219 · Cited by 83
Rincón‐Cervera, M. Á., Valenzuela, R., Hernández‐Rodas, M. C., Marambio, M., Espinosa, A., Mayer, S., Romero, N., Barrera, C. R., Valenzuela, A., & Videla, L. A. (2016) · Nutrition · doi:10.1016/j.nut.2016.04.006 · Cited by 87
Aliasghari, F., Izadi, A., Gargari, B. P., & Ebrahimi, S. (2017) · Journal of the American College of Nutrition · doi:10.1080/07315724.2017.1339644 · Cited by 84
Phillips, C. M., Dillon, C. B., & Perry, I. J. (2017) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-017-0594-8 · Cited by 88
Phelan, S., Wing, R. R., Brannen, A., McHugh, A., Hagobian, T. A., Schaffner, A. A., Jelalian, E., Hart, C. N., Scholl, T. O., Muñoz‐Christian, K., et al. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqx043 · Cited by 91
Periodontitis is associated with incident chronic liver disease—A population‐based cohort study
Helenius‐Hietala, J., Suominen, A. L., Ruokonen, H., Knuuttila, M. L. E., Puukka, P. J., Jula, A., Meurman, J. H., & Åberg, F. O. (2018) · Liver International · doi:10.1111/liv.13985 · Cited by 87
Physical activity in adolescents and children and relationship to metabolic health
Whooten, R., Kerem, L., & Stanley, T. L. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000455 · Cited by 83
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
